Photo of Neal Roach Jr.

Neal’s practice focuses on transactional matters for companies for whom technology is critical, with a focus on intellectual property licensing.  He has represented numerous startup and high-growth companies on a broad range of matters, including advice on intellectual property protection, management and licensing; contracts; FDA and other regulatory issues; corporate structure and governance; sales and marketing regulation; healthcare compliance; reimbursement; strategic partnership relationships. In addition, Neal frequently advises healthcare clients and life sciences companies regarding the application of HIPAA and state patient privacy laws. Neal currently serves as chairperson of Taft’s Technology Services industry group.

The U.S. Food and Drug Administration (FDA) issued a press release on March 3, 2020, to inform patients, health care providers and manufacturers about a newly discovered cybersecurity vulnerability. A vulnerability set referred to as “SweynTooth” affects wireless communication technology known as Bluetooth Low Energy (BLE). BLE allows two devices to “pair” and exchange information

Last summer, New York Governor Andrew Cuomo signed into law the Stop Hacks and Improve Electronic Data Security (SHIELD) Act. The SHIELD Act’s data breach notification requirements are already effective and the law’s data security requirements go into effect on March 21. Any company that does business in New York or has customers in New